Barclays »

Edesa Biotech shares owned by Barclays

Quarter-by-quarter ownership of Edesa Biotech (EDSA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Edesa Biotech

Tip: Access up to 7 years of quarterly data

All positions including Edesa Biotech held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edesa Biotech by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $13 6 2.33

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Edesa Biotech

Rubric Capital Management
Stonepine Capital Management
Velan Capital Investment Management
Nantahala Capital Management
Vanguard Group
Geode Capital Management
Commonwealth Equity Services
Renaissance Technologies
Susquehanna International
Citadel Advisors
UBS Group
Royal Bank of Canada
Tower Research Capital
Morgan Stanley
TD Waterhouse Canada

View all funds holding Edesa Biotech